Search Results - "Gruet, Michael"
-
1
Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma
Published in Nature communications (16-03-2022)“…Neuroblastoma is the most common paediatric solid tumour and prognosis remains poor for high-risk cases despite the use of multimodal treatment. Analysis of…”
Get full text
Journal Article -
2
Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma
Published in Cell reports (Cambridge) (31-10-2023)“…Ovarian high-grade serous carcinoma (HGSC) is the most common subtype of ovarian cancer with limited therapeutic options and a poor prognosis. In recent years,…”
Get full text
Journal Article -
3
Chemical tools for profiling the intracellular ADP-ribosylated proteome
Published in RSC chemical biology (03-07-2024)“…The post-translational modification (PTM) ADP-ribosylation plays an important role in cell signalling and regulating protein function and has been implicated…”
Get full text
Journal Article -
4
β2-Adrenergic Signalling Promotes Cell Migration by Upregulating Expression of the Metastasis-Associated Molecule LYPD3
Published in Biology (Basel, Switzerland) (22-02-2020)“…Metastasis is associated with poor prognosis in breast cancer. Although some studies suggest beta-blockers increase survival by delaying metastasis, others…”
Get full text
Journal Article -
5
Abstract B096: Targeting RNA splicing factor RBM39 improves therapy responses in ovarian high-grade serous carcinoma
Published in Cancer research (Chicago, Ill.) (04-03-2024)“…Abstract Ovarian high-grade serous carcinoma (HGSC) is the most common subtype of ovarian cancer with limited therapeutic options and poor prognosis. In recent…”
Get full text
Journal Article